Aequus Pharmaceuticals Stock Performance
| AQS Stock | CAD 0.01 0.01 100.00% |
Aequus Pharmaceuticals holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 4.98, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aequus Pharmaceuticals will likely underperform. Use Aequus Pharmaceuticals treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to analyze future returns on Aequus Pharmaceuticals.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aequus Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Aequus Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Aequus Pharmaceuticals Reports Revenue Growth Amid Restructuring - TipRanks | 11/08/2024 |
| Begin Period Cash Flow | 249.8 K |
Aequus |
Aequus Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 1.50 in Aequus Pharmaceuticals on August 31, 2024 and sell it today you would lose (0.50) from holding Aequus Pharmaceuticals or give up 33.33% of portfolio value over 90 days. Aequus Pharmaceuticals is currently producing 2.9032% returns and takes up 27.1237% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Aequus, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Aequus Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aequus Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aequus Pharmaceuticals, and traders can use it to determine the average amount a Aequus Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.107
| Best Portfolio | Best Equity | |||
| Good Returns | AQS | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 27.12 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.9 actual daily | 57 57% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Aequus Pharmaceuticals is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aequus Pharmaceuticals by adding it to a well-diversified portfolio.
Aequus Pharmaceuticals Fundamentals Growth
Aequus Stock prices reflect investors' perceptions of the future prospects and financial health of Aequus Pharmaceuticals, and Aequus Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aequus Stock performance.
| Return On Equity | -15.7 | ||||
| Return On Asset | -1.58 | ||||
| Operating Margin | (4.15) % | ||||
| Current Valuation | 7.84 M | ||||
| Shares Outstanding | 132.63 M | ||||
| Price To Earning | (1.85) X | ||||
| Price To Book | 24.39 X | ||||
| Price To Sales | 3.21 X | ||||
| Revenue | 254.9 K | ||||
| Gross Profit | 2.69 M | ||||
| EBITDA | (2.68 M) | ||||
| Net Income | (2.96 M) | ||||
| Cash And Equivalents | 1.46 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 5.06 M | ||||
| Debt To Equity | 248.30 % | ||||
| Current Ratio | 4.37 X | ||||
| Book Value Per Share | (0.05) X | ||||
| Cash Flow From Operations | (2.29 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 1.33 M | ||||
| Total Asset | 1.09 M | ||||
| Retained Earnings | (32.68 M) | ||||
| Working Capital | (4.36 M) | ||||
About Aequus Pharmaceuticals Performance
Evaluating Aequus Pharmaceuticals' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Aequus Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aequus Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 181.11 | 172.05 | |
| Return On Tangible Assets | (2.73) | (2.87) | |
| Return On Capital Employed | 0.76 | 1.28 | |
| Return On Assets | (2.73) | (2.87) | |
| Return On Equity | 0.69 | 0.72 |
Things to note about Aequus Pharmaceuticals performance evaluation
Checking the ongoing alerts about Aequus Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aequus Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aequus Pharmaceuticals is way too risky over 90 days horizon | |
| Aequus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aequus Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Aequus Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Aequus Pharmaceuticals has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 254.9 K. Net Loss for the year was (2.96 M) with profit before overhead, payroll, taxes, and interest of 2.69 M. | |
| Aequus Pharmaceuticals has accumulated about 1.46 M in cash with (2.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Aequus Pharmaceuticals Reports Revenue Growth Amid Restructuring - TipRanks |
- Analyzing Aequus Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aequus Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Aequus Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aequus Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aequus Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aequus Pharmaceuticals' stock. These opinions can provide insight into Aequus Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.